Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol

NCT00549133 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00549133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00549133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
April 30, 2005
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, hypertension